-
, in parallel, explore CRISPR and AAV technologies to develop new ocular gene therapy. We have all multidisciplinary facilities, technology and expertise needed directly at our disposal. The candidate
-
under control and MS relevant inflammatory conditions. You will: Further develop white and grey matter stem cell co-cultures; Develop and perform experiments to address the research questions formulated
-
Alzheimer’s disease such as ApoE4. In this PhD project, you will apply this previous knowledge to develop cellular screening assays in order to identify novel candidate interventions for Alzheimer’s disease
-
. About the role You will first be stationed for 1.5 years at the Vrije Universiteit in Amsterdam to develop a set of tools to assess listening value in real-life occupational settings through self-report
-
receptor types, how this determines immunity, and develop novel tools to block pathogen binding to CLRs and Siglec receptors. For this you will isolate, produce and characterize nanobodies that can bind CLRs
-
or carried out their main activity (work, studies, etc.) in the Netherlands for more than 12 months in the 3 years immediately before the recruitment date. Your education has to correspond to a four- to five
-
including an 8.3% end-of-year bonus and 8% holiday pay. Calculate your net salary here . Your pension is accrued at The Dutch Pension Fund for government and education employees (ABP). Amsterdam UMC
-
and benefits of effortful listening. EASYLI will train 6 doctoral candidates to develop and apply a toolbox of ambulatory and laboratory measures to assess listening effort in occupational settings in
-
years. The position is for 4 years. The opportunity to develop further such as through training. Classification in salary scale OIO: € 2,901 to € 3,677 gross for full-time employment (depending
-
staff position within a Research Infrastructure? No Offer Description The new European AD–RIDDLE project aims to develop, test, and deploy a modular toolbox platform that can reduce existing barriers